Dopamine, immunity, and disease
B Channer, SM Matt, EA Nickoloff-Bybel, V Pappa… - Pharmacological …, 2023 - ASPET
The neurotransmitter dopamine is a key factor in central nervous system (CNS) function,
regulating many processes including reward, movement, and cognition. Dopamine also …
regulating many processes including reward, movement, and cognition. Dopamine also …
Therapeutic potential of quercetin in the management of type-2 diabetes mellitus
Diabetes Mellitus (DM) is a metabolic disorder that is spreading alarmingly around the
globe. Type-2 DM (T2DM) is characterized by low-grade inflammation and insulin resistance …
globe. Type-2 DM (T2DM) is characterized by low-grade inflammation and insulin resistance …
A growing link between circadian rhythms, type 2 diabetes mellitus and Alzheimer's disease
X Peng, R Fan, L Xie, X Shi, K Dong, S Zhang… - International journal of …, 2022 - mdpi.com
Type 2 diabetes mellitus (T2DM) patients are at a higher risk of developing Alzheimer's
disease (AD). Mounting evidence suggests the emerging important role of circadian rhythms …
disease (AD). Mounting evidence suggests the emerging important role of circadian rhythms …
[HTML][HTML] Whole-brain activation signatures of weight-lowering drugs
HH Hansen, J Perens, U Roostalu, JL Skytte… - Molecular …, 2021 - Elsevier
Objective The development of effective anti-obesity therapeutics relies heavily on the ability
to target specific brain homeostatic and hedonic mechanisms controlling body weight. To …
to target specific brain homeostatic and hedonic mechanisms controlling body weight. To …
A recent achievement in the discovery and development of novel targets for the treatment of type-2 diabetes mellitus
TM Belete - Journal of experimental pharmacology, 2020 - Taylor & Francis
Abstract Type 2 diabetes (T2DM) is a chronic metabolic disorder. Impaired insulin secretion,
enhanced hepatic glucose production, and suppressed peripheral glucose use are the main …
enhanced hepatic glucose production, and suppressed peripheral glucose use are the main …
Intrinsic and antipsychotic drug-induced metabolic dysfunction in schizophrenia
Z Freyberg, D Aslanoglou, R Shah… - Frontiers in …, 2017 - frontiersin.org
For decades, there have been observations demonstrating significant metabolic
disturbances in people with schizophrenia including clinically relevant weight gain …
disturbances in people with schizophrenia including clinically relevant weight gain …
Diabetes mellitus secondary to Cushing's disease
Associated with important comorbidities that significantly reduce patients' overall wellbeing
and life expectancy, Cushing's disease (CD) is the most common cause of endogenous …
and life expectancy, Cushing's disease (CD) is the most common cause of endogenous …
Diabetes and dyslipidemia
KR Feingold, C Grunfeld - Diabetes And Cardiovascular Disease, 2023 - Springer
Atherosclerotic cardiovascular disease (ASCVD) is a major cause of morbidity and mortality
in both men and women with type 1 and type 2 diabetes. There are numerous risk factors …
in both men and women with type 1 and type 2 diabetes. There are numerous risk factors …
Association between serum prolactin levels and insulin resistance in non-diabetic men
M Daimon, A Kamba, H Murakami, S Mizushiri… - PLoS …, 2017 - journals.plos.org
Prolactin (PRL) has roles in various physiological functions. Although experimental studies
showed that PRL has both beneficial and adverse effects on type 2 diabetes mellitus, clinical …
showed that PRL has both beneficial and adverse effects on type 2 diabetes mellitus, clinical …
Hypothalamic dopamine signalling regulates brown fat thermogenesis
C Folgueira, D Beiroa, B Porteiro, M Duquenne… - Nature …, 2019 - nature.com
Dopamine signalling is a crucial part of the brain reward system and can affect feeding
behaviour. Dopamine receptors are also expressed in the hypothalamus, which is known to …
behaviour. Dopamine receptors are also expressed in the hypothalamus, which is known to …